Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Joe R. Anderson"'
Autor:
Joe R. Anderson, Pharm. D., Gireesh V. Gupchup, Ph.D., F.A.Ph.A., Lisa R. Marr-Lyon, Ph.D., M.Ed.
Publikováno v:
INNOVATIONS in Pharmacy, Vol 4, Iss 1, p 108 (2013)
Introduction: Since the development of the 10 item Purdue Pharmacist Directive Guidance (PPDG) Scale several studies of the psychometric properties of the PPDG have been conducted. Although Cronbach’s alpha was calculated as a means of internal con
Externí odkaz:
https://doaj.org/article/4fe63787e75d482fa82aca754b797087
Autor:
Joe R. Anderson, Luis de Jesus Gonzalez, Preeyaporn Sarangarm, Patricia L. Marshik, Tracy S. Hunter, Nathan L. Duran, Gretchen M. Ray
Publikováno v:
Journal of the American Pharmacists Association. 62:1364-1368
This study aimed to describe and compare the public's change in awareness and perceptions of, willingness to use, willingness to pay, and interest in insurance coverage for community pharmacist prescriptive authority services and point of care testin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9090db14f6e954ca7382d10743c0794a
https://doi.org/10.1016/j.japh.2021.12.008
https://doi.org/10.1016/j.japh.2021.12.008
Publikováno v:
Diabetes. 71
The goal of heart failure (HF) pharmacotherapy is to improve disease-related morbidity and mortality. Recent clinical trials demonstrated a reduction in cardiovascular death and HF-related hospitalizations with the addition of sodium glucose co-trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8920b5f9c747200886a468f52f2c983
https://doi.org/10.2337/db22-121-lb
https://doi.org/10.2337/db22-121-lb
Autor:
Meera Shah, Joe R. Anderson, Abinash Achrekar, Mary T. Walsh-Wilcox, Mary K. Walker, Emily Wheeler
Publikováno v:
Cardiovasc Toxicol
Active smoking and secondhand smoke (SHS) exposure increase the risk of cardiovascular morbidity and mortality. Active smoking is associated with reduced levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) and studies show that n-3 PUFA suppleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf1af483fa996a3cea333c6f9bc6bdd4
https://doi.org/10.1007/s12012-020-09601-6
https://doi.org/10.1007/s12012-020-09601-6
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 62(2)
Background Atrial fibrillation (AF) increases the risk of stroke. It can be asymptomatic and patients may be unaware they have AF. Therefore, there is a need to develop a sustainable community model to screen for unrecognized AF. Objective The object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a4729141dab654310faf3f97f1630dc
https://pubmed.ncbi.nlm.nih.gov/34772632
https://pubmed.ncbi.nlm.nih.gov/34772632
Autor:
Barbara H. Brumbach, Kayla R Zehr, Allison Segovia, Mary T. Walsh-Wilcox, Meera Shah, Joe R. Anderson, Mary K. Walker
Publikováno v:
Prostaglandins Leukot Essent Fatty Acids
Epidemiology studies and clinical trials have shown that omega-3 polyunsaturated fatty acids (n-3 PUFAs) are inversely associated with blood pressure. We sought to determine the influence of cigarette smoking and Hispanic ethnicity on this associatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603c9ff4babb32a4ed879819542efbee
https://europepmc.org/articles/PMC6521860/
https://europepmc.org/articles/PMC6521860/
Publikováno v:
Cardiology in Review. 24:141-152
Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors are novel agents indicated for the treatment of hyperlipidemia. Inhibition of PCSK9 produces an increase in surface low-density lipoprotein (LDL) receptors and increases removal of LDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea08bc1e63f080fc52963389725b5f2
https://doi.org/10.1097/crd.0000000000000102
https://doi.org/10.1097/crd.0000000000000102
Publikováno v:
Cardiology in Review. 24:41-47
Sacubitril/valsartan [LCZ696 (Entresto), Novartis Pharmaceuticals Corp.] is the first in a new class of drugs that combines neprilysin inhibition with angiotensin II receptor antagonism, the combination of which acts to increase endogenous natriureti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15de5f2e11aacb5af22fc26340941176
https://doi.org/10.1097/crd.0000000000000093
https://doi.org/10.1097/crd.0000000000000093
Autor:
Amy Bachyrycz, Patricia Marshik, James J. Nawarskas, Matthew E. Borrego, Krista Salazar, Melanie A. Dodd, Gretchen M. Ray, Bernadette Jakeman, Renee-Claude Mercier, Joe R. Anderson, Paulina Deming, A.A. Kharat, Rucha Bond
Publikováno v:
The Journal of Alternative and Complementary Medicine. 22:45-51
To describe differences, attitudes, and experiences in use of complementary and alternative medicines and therapy (CAMT) in people living in New Mexico (NM).Cross-sectional survey study.Clinics staffed by the University of New Mexico College of Pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39060ef34aa599202b862a37936f9a4d
https://doi.org/10.1089/acm.2014.0378
https://doi.org/10.1089/acm.2014.0378
Publikováno v:
Toxicology Letters. 232:422-428
Impaired flow-mediated dilation (FMD) occurs prior to clinical disease in young cigarette smokers. We investigated two potential biomarkers of FMD: serum aryl hydrocarbon receptor (AHR) activity and RBC omega-3 polyunsaturated fatty acids in healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969aa0023711a7abd263750243091430
https://doi.org/10.1016/j.toxlet.2014.12.002
https://doi.org/10.1016/j.toxlet.2014.12.002